脑肿瘤强化显示与形态学评估:MPRAGE、SPACE与VIBE MRI技术的比较
研究纳入54个强化肿瘤(38例胶质瘤、16例转移瘤),在3T扫描仪上随机采用MPRAGE、VIBE和SPACE技术行钆增强后MR成像,比较肿瘤强化显示与靶物体形态学测量。与MPRAGE相比,SPACE和VIBE在胶质瘤和转移瘤中均获得更高的对比率、对比噪声比和视觉显示评分;序列间3D靶物体边缘差异范围为肿瘤体积的3%至19.9%,SPACE获得更大的肿瘤体积及1D、2D测量值。
要点
- SPACE和VIBE显示脑肿瘤强化优于MPRAGE,胶质瘤和转移瘤中对比率、对比噪声比及视觉评分均更高。
- 序列间3D靶物体边缘差异达肿瘤体积的3%至19.9%,形态学测量需注意序列选择影响。
- SPACE获得更大的肿瘤体积及1D、2D测量值,作者认为SPACE提供更准确的估计。
核心结论
- 与MPRAGE相比,SPACE和VIBE技术可获得更优的脑肿瘤强化显示;评估靶物体大小和形态时也检测到序列间差异,其中SPACE提供更准确的估计。
研究设计与样本
- 比较研究,纳入54个强化肿瘤(38例胶质瘤、16例转移瘤),在3T扫描仪上钆对比剂给药后随机采用MPRAGE、VIBE和SPACE技术采集,以计算机辅助神经导航软件勾画的对应3D靶物体为参考。
关键影像表现/征象
- 与MPRAGE相比,SPACE和VIBE在胶质瘤和转移瘤中均获得更高的对比率、对比噪声比和视觉显示评分(P范围<.001-.001)。
- 序列间3D靶物体边缘差异范围为肿瘤体积的3%至19.9%。
- SPACE获得更大的肿瘤体积、1D和2D测量值(P范围<.01-.007)。
诊断标准与关键数值
- 强化显示定量评估采用对比率和对比噪声比,定性评估采用共识视觉比较评分。
- 形态学评估包括3D靶物体总体积、边缘 delineation 序列间差异,以及1D(RECIST)和2D(RANO)测量。
临床应用与阅片要点
- 脑肿瘤强化显示及形态学测量时需注意序列选择对靶物体边缘和体积测量的影响,序列间边缘差异可达肿瘤体积的3%至19.9%。
- SPACE和VIBE较MPRAGE显示强化更清晰,SPACE获得更大的体积及1D、2D测量值,作者认为SPACE提供更准确的估计。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Postgadolinium MR imaging is crucial for brain tumor diagnosis and morphometric assessment. We compared brain tumor enhancement visualization and the "target" object morphometry obtained with the most commonly used 3D MR imaging technique, MPRAGE, with 2 other routinely available techniques: sampling perfection with application-optimized contrasts by using different flip angle evolutions (SPACE) and volumetric interpolated brain examination (VIBE).
MATERIALS AND METHODS: Fifty-four contrast-enhancing tumors (38 gliomas and 16 metastases) were assessed using MPRAGE, VIBE, and SPACE techniques randomly acquired after gadolinium-based contrast agent administration on a 3T scanner. Enhancement conspicuity was assessed quantitatively by calculating the contrast rate and contrast-to-noise ratio, and qualitatively, by consensus visual comparative ratings. The total enhancing tumor volume and between-sequence discrepancy in the margin delineation were assessed on the corresponding 3D target objects contoured with a computer-assisted software for neuronavigation. The Wilcoxon signed rank and Pearson χ2 nonparametric tests were used to investigate between-sequence discrepancies in the contrast rate, contrast-to-noise ratio, visual conspicuity ratings, tumor volume, and margin delineation estimates. Differences were also tested for 1D (Response Evaluation Criteria in Solid Tumors) and 2D (Response Assessment in Neuro-Oncology) measurements.
RESULTS: Compared with MPRAGE, both SPACE and VIBE obtained higher contrast rate, contrast-to-noise ratio, and visual conspicuity ratings in both gliomas and metastases (P range, <.001-.001). The between-sequence 3D target object margin discrepancy ranged between 3% and 19.9% of lesion tumor volume. Larger tumor volumes, 1D and 2D measurements were obtained with SPACE (P range, <.01-.007).
CONCLUSIONS: Superior conspicuity for brain tumor enhancement can be achieved using SPACE and VIBE techniques, compared with MPRAGE. Discrepancies were also detected when assessing target object size and morphology, with SPACE providing more accurate estimates.
引用
- Danieli L, Riccitelli GC, Distefano D, et al. Brain Tumor-Enhancement Visualization and Morphometric Assessment: A Comparison of MPRAGE, SPACE, and VIBE MRI Techniques. AJNR Am J Neuroradiol. 2019. PMID: 31221635. doi:10.3174/ajnr.A6096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。